From clinical, cellular, and tumor-bearing mouse levels, Xu et al. demonstrated that zinc finger protein 217 (ZNF217) silencing or miR-135 elevation inhibited BC cell migration, invasion, and EMT initiation (Xu et al., 2022). The gene discussed is ZNF217; the disease is breast cancer.